Literature DB >> 12927390

Evaluation of childhood exposure to di(2-ethylhexyl) phthalate from perfusion kits during long-term parenteral nutrition.

K Kambia1, T Dine, B Gressier, S Bah, A-F Germe, M Luyckx, C Brunet, L Michaud, F Gottrand.   

Abstract

Leachability of the plasticizer di(2-ethylhexyl) phthalate (DEHP) from administration sets into intravenous parenteral emulsions containing fat was investigated. DEHP is added to polyvinyl chloride (PVC) to impart flexibility. However, DEHP is a lipid-soluble suspected carcinogen that is hepatotoxic and teratogenic in rodents, and has been shown to leach from PVC products containing lipophilic mixtures. Consequently, total parenteral nutrition (TPN) mixtures containing fat emulsions should be stored in ethylvinyl acetate (EVA) bags rather than PVC packs. However, while TPN bags are made of EVA, they contain PVC-DEHP residues and the lines used between TPN bags and venous catheters are made of PVC-DEHP. The present study quantified the amount of DEHP leached from bags and tubing that could potentially contaminate patients during home TPN. Four types of emulsions containing fat were studied. Levels of DEHP in the bag and at the outlet tubing were measured by high-performance liquid chromatography (HPLC). This was measured during simulated TPN at different times after starting perfusion, 1 day after reconstitution of solutions in the bags, and 1 week later after storage at 4 degrees C. Detectable and stable amounts of DEHP were found to leach from bags (0.2 +/- 0.008 mg to 0.7 +/- 0.02 mg) and DEHP content increased in the outlet tubing (0.8 +/- 0.09 mg to 2 +/- 0.07 mg) during simulated infusions. The same phenomenon was observed after 1 week of storage at 4 degrees C. DEHP extraction by TPN depends on the lipid content of each TPN preparation and the flow rate. These results suggest that children treated with prolonged TPN are regularly exposed to significant amounts of DEHP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927390     DOI: 10.1016/s0378-5173(03)00335-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Inflammatory effects of phthalates in neonatal neutrophils.

Authors:  Anna M Vetrano; Debra L Laskin; Faith Archer; Kirin Syed; Joshua P Gray; Jeffrey D Laskin; Nkiru Nwebube; Barry Weinberger
Journal:  Pediatr Res       Date:  2010-08       Impact factor: 3.756

2.  A review of alternatives to di (2-ethylhexyl) phthalate-containing medical devices in the neonatal intensive care unit.

Authors:  E D S Van Vliet; E M Reitano; J S Chhabra; G P Bergen; R M Whyatt
Journal:  J Perinatol       Date:  2011-02-10       Impact factor: 2.521

3.  Exposure of hospitalised pregnant women to plasticizers contained in medical devices.

Authors:  Cécile Marie; Sebti Hamlaoui; Lise Bernard; Daniel Bourdeaux; Valérie Sautou; Didier Lémery; Françoise Vendittelli; Marie-Pierre Sauvant-Rochat
Journal:  BMC Womens Health       Date:  2017-06-20       Impact factor: 2.809

Review 4.  Airborne environmental injuries and human health.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2006-08       Impact factor: 8.667

5.  Risk Assessment of Phthalates and Their Metabolites in Hospitalized Patients: A Focus on Di- and Mono-(2-ethylhexyl) Phthalates Exposure from Intravenous Plastic Bags.

Authors:  Yolande Saab; Emilia Oueis; Stephanie Mehanna; Zahi Nakad; Rita Stephan; Rony S Khnayzer
Journal:  Toxics       Date:  2022-06-30

6.  Injection device-related risk management toward safe administration of medications: experience in a university teaching hospital in The People's Republic of China.

Authors:  Ling-Ling Zhu; Wei Li; Ping Song; Quan Zhou
Journal:  Ther Clin Risk Manag       Date:  2014-03-17       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.